{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:37:10Z","timestamp":1790836630680,"version":"4.1.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest Radiol"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>This preclinical study was designed to compare gadolinium (Gd) brain uptake after repeated injections of a macrocyclic Gd-based contrast agent (GBCA) (gadoterate meglumine) or 2 linear GBCAs (L-GBCAs) (gadobenate dimeglumine or gadodiamide) on a translational model of moderate renal impairment in rats.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study was carried out in subtotally nephrectomized rats. Animals received 4 intravenous injections per week of GBCA (gadoterate meglumine, gadobenate dimeglumine, or gadodiamide) for 5 weeks, resulting in a cumulative dose of 12 mmol\/kg, followed by a 1-month injection-free period. T1 hyperintensity in the deep cerebellar nuclei (DCNs) was investigated, and brain structures were carefully dissected to determine elemental Gd, iron (Fe), copper (Cu), and zinc (Zn) distribution by mass spectrometry. Urinary excretion of endogenous metals was also investigated soon after GBCA administration and several days later in order to assess a potential transmetalation phenomenon.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Unlike gadoterate, repeated injections of L-GBCAs gadobenate and gadodiamide both induced T1 hyperintensity in the DCNs. Fine dissection of cerebral and cerebellar structures demonstrated very low levels or absence of Gd after repeated injections of gadoterate, in contrast to the two L-GBCAs, for which the highest total Gd concentration was demonstrated in the DCNs (Gd concentration in DCNs after 4.5 weeks of injection-free period: 27.1 \u00b1 6.5 nmol\/g for gadodiamide [<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01 vs saline and <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05 vs gadoterate]; 12.0 \u00b1 2.6 nmol\/g for gadobenate [<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.09 vs saline]; compared with 1.4 \u00b1 0.2 nmol\/g for gadoterate [ns vs saline]). The distribution of Gd concentration among the various brain structures dissected was also well correlated with the Fe distribution in these structures. No difference in endogenous metal levels in brain structures was observed. However, injection of gadobenate or gadodiamide resulted in an increase in urinary Zn excretion (urinary Zn concentrations: 57.9 \u00b1 20.5 nmol\/mL with gadobenate [<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01 vs gadoterate and saline] and 221.6 \u00b1 83.3 nmol\/L with gadodiamide [<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001 vs all other treatments] vs 8.1 \u00b1 2.3 nmol\/L with saline and 10.6 \u00b1 4.8 nmol\/L with gadoterate]).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In a model of renally impaired rats, only traces of gadoterate meglumine were detected in the brain with no T1 hyperintensity of the DCNs, whereas marked Gd retention was observed in almost all brain areas after injections of the L-GBCAs, gadobenate dimeglumine and gadodiamide. Brain structures with higher Gd uptake corresponded to those structures containing more Fe. Urinary Zn excretion was significantly increased after a single injection of L-GBCAs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rli.0000000000000447","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T17:07:45Z","timestamp":1515776865000},"page":"328-337","source":"Crossref","is-referenced-by-count":54,"title":["Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals"],"prefix":"10.1097","volume":"53","author":[{"given":"Marl\u00e8ne","family":"Rasschaert","sequence":"first","affiliation":[{"name":"From the *Guerbet Research and Innovation Department, Aulnay-sous-Bois; and \u2020INSERM, U1196; \u2021Institut Curie, PSL Research University; \u00a7Universit\u00e9 Paris Sud; \u2225Universit\u00e9 Paris-Saclay; and \u00b6CNRS, UMR 9187, Orsay, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a","family":"Emerit","sequence":"additional","affiliation":[{"name":"From the *Guerbet Research and Innovation Department, Aulnay-sous-Bois; and \u2020INSERM, U1196; \u2021Institut Curie, PSL Research University; \u00a7Universit\u00e9 Paris Sud; \u2225Universit\u00e9 Paris-Saclay; and \u00b6CNRS, UMR 9187, Orsay, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Fretellier","sequence":"additional","affiliation":[{"name":"From the *Guerbet Research and Innovation Department, Aulnay-sous-Bois; and \u2020INSERM, U1196; \u2021Institut Curie, PSL Research University; \u00a7Universit\u00e9 Paris Sud; \u2225Universit\u00e9 Paris-Saclay; and \u00b6CNRS, UMR 9187, Orsay, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Factor","sequence":"additional","affiliation":[{"name":"From the *Guerbet Research and Innovation Department, Aulnay-sous-Bois; and \u2020INSERM, U1196; \u2021Institut Curie, PSL Research University; \u00a7Universit\u00e9 Paris Sud; \u2225Universit\u00e9 Paris-Saclay; and \u00b6CNRS, UMR 9187, Orsay, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Robert","sequence":"additional","affiliation":[{"name":"From the *Guerbet Research and Innovation Department, Aulnay-sous-Bois; and \u2020INSERM, U1196; \u2021Institut Curie, PSL Research University; \u00a7Universit\u00e9 Paris Sud; \u2225Universit\u00e9 Paris-Saclay; and \u00b6CNRS, UMR 9187, Orsay, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Id\u00e9e","sequence":"additional","affiliation":[{"name":"From the *Guerbet Research and Innovation Department, Aulnay-sous-Bois; and \u2020INSERM, U1196; \u2021Institut Curie, PSL Research University; \u00a7Universit\u00e9 Paris Sud; \u2225Universit\u00e9 Paris-Saclay; and \u00b6CNRS, UMR 9187, Orsay, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Corot","sequence":"additional","affiliation":[{"name":"From the *Guerbet Research and Innovation Department, Aulnay-sous-Bois; and \u2020INSERM, U1196; \u2021Institut Curie, PSL Research University; \u00a7Universit\u00e9 Paris Sud; \u2225Universit\u00e9 Paris-Saclay; and \u00b6CNRS, UMR 9187, Orsay, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231021","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10534-008-9135-x","article-title":"Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review","volume":"21","year":"2008","journal-title":"Biometals"},{"key":"bib2-20231021","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/RLI.0000000000000241","article-title":"Linear gadolinium-based contrast agents are associated with brain gadolinium retention in healthy rats","volume":"51","year":"2016","journal-title":"Invest Radiol"},{"key":"bib3-20231021","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/RLI.0000000000000242","article-title":"Signal increase on unenhanced T1-weighted images in the rat brain after repeated, extended doses of gadolinium-based contrast agents: comparison of linear and macrocyclic agents","volume":"51","year":"2016","journal-title":"Invest Radiol"},{"key":"bib4-20231021","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.rli.0000186569.32408.95","article-title":"Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy","volume":"41","year":"2006","journal-title":"Invest Radiol"},{"key":"bib5-20231021","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/RLI.0000000000000072","article-title":"Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation","volume":"49","year":"2014","journal-title":"Invest Radiol"},{"key":"bib6-20231021","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/RLI.0000000000000206","article-title":"Increased signal intensity in the dentate nucleus on unenhanced T1-weighted images after gadobenate dimeglumine administration","volume":"50","year":"2015","journal-title":"Invest Radiol"},{"key":"bib7-20231021","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1148\/radiol.15150025","article-title":"Intracranial gadolinium deposition after contrast-enhanced MR imaging","volume":"275","year":"2015","journal-title":"Radiology"},{"key":"bib8-20231021","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiol.2015150337","article-title":"Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent","volume":"275","year":"2015","journal-title":"Radiology"},{"key":"bib9-20231021","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1148\/radiol.13131669","article-title":"High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material","volume":"270","year":"2014","journal-title":"Radiology"},{"key":"bib10-20231021","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/RLI.0000000000000308","article-title":"Intraindividual analysis of signal intensity changes in the dentate nucleus after consecutive serial applications of linear and macrocyclic gadolinium-based contrast agents","volume":"51","year":"2016","journal-title":"Invest Radiol"},{"key":"bib11-20231021","doi-asserted-by":"crossref","first-page":"20160509","DOI":"10.1259\/bjr.20160509","article-title":"Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model","volume":"89","year":"2016","journal-title":"Br J Radiol"},{"key":"bib12-20231021","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/RLI.0000000000000344","article-title":"Histology and gadolinium distribution in the rodent brain after the administration of cumulative high doses of linear and macrocyclic gadolinium-based contrast agents","volume":"52","year":"2017","journal-title":"Invest Radiol"},{"key":"bib13-20231021","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/RLI.0000000000000412","article-title":"A Pharmacokinetics, efficacy, and safety study of gadoterate meglumine in pediatric subjects aged younger than 2 years","volume":"53","year":"2018","journal-title":"Invest Radiol"},{"key":"bib14-20231021","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3174\/ajnr.A4891","article-title":"Pediatric patients demonstrate progressive T1-weighted hyperintensity in the dentate nucleus following multiple doses of gadolinium-based contrast agent","volume":"37","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib15-20231021","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/RLI.0000000000000419","article-title":"Comparison of unenhanced T1-weighted signal intensities within the dentate nucleus and the globus pallidus after serial applications of gadopentetate dimeglumine versus gadobutrol in a pediatric population","volume":"53","year":"2018","journal-title":"Invest Radiol"},{"key":"bib16-20231021","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1148\/radiol.2017162534","article-title":"Gadolinium chelate safety in pregnancy: barely detectable gadolinium levels in the juvenile nonhuman primate after in utero exposure","volume":"286","year":"2018","journal-title":"Radiology"},{"key":"bib17-20231021","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s11604-017-0667-2","article-title":"Organ retention of gadolinium in mother and pup mice: effect of pregnancy and type of gadolinium-based contrast agents","volume":"35","year":"2017","journal-title":"Jpn J Radiol"},{"key":"bib18-20231021","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/RLI.0000000000000417","article-title":"The effect of perinatal gadolinium-based contrast agents on adult mice behavior","volume":"53","year":"2018","journal-title":"Invest Radiol"},{"key":"bib19-20231021","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cmmi.1683","article-title":"High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification","volume":"11","year":"2016","journal-title":"Contrast Media Mol Imaging"},{"key":"bib20-20231021","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/RLI.0000000000000294","article-title":"Effect of renal function on gadolinium-related signal increases on unenhanced T1-weighted brain magnetic resonance imaging","volume":"51","year":"2016","journal-title":"Invest Radiol"},{"key":"bib21-20231021","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nrn877","article-title":"Animal models of neurological deficits: how relevant is the rat?","volume":"3","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"bib22-20231021","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4419-5819-8_3","article-title":"Animal models of neurological disease","volume":"671","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"bib23-20231021","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/RLI.0000000000000339","article-title":"Moderate renal failure accentuates T1 signal enhancement in the deep cerebellar nuclei of gadodiamide-treated rats","volume":"52","year":"2017","journal-title":"Invest Radiol"},{"key":"bib24-20231021","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/j.ackd.2010.03.010","article-title":"Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance","volume":"17","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"bib25-20231021","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11606-008-0850-3","article-title":"High prevalence of stage 3 chronic kidney disease in older adults despite normal serum creatinine","volume":"24","year":"2009","journal-title":"J Gen Intern Med"},{"key":"bib31-20231021","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","article-title":"An analysis of variance test for normality (complete samples)","volume":"52","year":"1965","journal-title":"Biometrika"},{"key":"bib32-20231021","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1148\/radiol.2016160905","article-title":"Clearance of gadolinium from the brain with no pathologic effect after repeated administration of gadodiamide in healthy rats: an analytical and histologic study","volume":"282","year":"2017","journal-title":"Radiology"},{"key":"bib33-20231021","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/RLI.0000000000000352","article-title":"Quantification and assessment of the chemical form of residual gadolinium in the brain after repeated administration of gadolinium-based contrast agents: comparative study in rats","volume":"52","year":"2017","journal-title":"Invest Radiol"},{"key":"bib34-20231021","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiol.2017162857","article-title":"Gadolinium retention in the rat brain: assessment of the amounts of insoluble gadolinium-containing species and intact gadolinium complexes after repeated administration of gadolinium-based contrast agents","volume":"285","year":"2017","journal-title":"Radiology"},{"key":"bib35-20231021","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.toxlet.2014.06.019","article-title":"Manganese accumulation in bone following chronic exposure in rats: steady-state concentration and half-life in bone","volume":"229","year":"2014","journal-title":"Toxicol Lett"},{"key":"bib36-20231021","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/toxsci\/kfr033","article-title":"Manganese accumulation in the olfactory bulbs and other brain regions of \u201casymptomatic\u201d welders","volume":"121","year":"2011","journal-title":"Toxicol Sci"},{"key":"bib37-20231021","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1148\/radiol.2016152864","article-title":"Extent of signal hyperintensity on unenhanced T1-weighted brain MR images after more than 35 administrations of linear gadolinium-based contrast agents","volume":"282","year":"2017","journal-title":"Radiology"},{"key":"bib38-20231021","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1471-4159.1958.tb12607.x","article-title":"The effect of age on the non-haemin iron in the human brain","volume":"3","year":"1958","journal-title":"J Neurochem"},{"issue":"suppl 1","key":"bib39-20231021","first-page":"S181","article-title":"Pharmacokinetics and tissue distribution in animals of gadobenate ion, the magnetic resonance imaging contrast enhancing component of gadobenate dimeglumine 0.5 M solution for injection (MultiHance)","volume":"23","year":"1999","journal-title":"J Comput Assist Tomogr"},{"key":"bib40-20231021","doi-asserted-by":"crossref","first-page":"20140526","DOI":"10.1259\/bjr.20140526","volume":"88","year":"2015","journal-title":"Br J Radiol"},{"key":"bib41-20231021","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/jmri.21135","article-title":"Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis","volume":"26","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"bib42-20231021","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1476-5381.2011.01585.x","article-title":"Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide","volume":"165","year":"2012","journal-title":"Br J Pharmacol"},{"key":"bib43-20231021","first-page":"322","article-title":"Human comparative study of zinc and copper excretion via urine after administration of magnetic resonance imaging contrast agents","volume":"23","year":"2005","journal-title":"Radiat Med"},{"key":"bib44-20231021","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2144\/06404RR02","article-title":"Use of a zinc fluorophore to measure labile pools of zinc in body fluids and cell-conditioned media","volume":"40","year":"2006","journal-title":"Biotechniques"},{"key":"bib45-20231021","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4155\/fmc.09.140","article-title":"Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders [review]","volume":"2","year":"2010","journal-title":"Future Med Chem"},{"key":"bib46-20231021","first-page":"45","article-title":"Labile iron in cells and body fluids: physiology, pathology, and pharmacology [review]","volume":"5","year":"2014","journal-title":"Front Pharmacol"},{"key":"bib47-20231021","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/jmri.21967","article-title":"Role of thermodynamic and kinetic parameters in gadolinium chelate stability","volume":"30","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"bib48-20231021","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0730-725X(91)90429-P","article-title":"Reaction of gadolinium chelates with endogenously available ions","volume":"9","year":"1991","journal-title":"Magn Reson Imaging"},{"key":"bib49-20231021","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/cmmi.1500","article-title":"Gadolinium-containing magnetic resonance contrast media: investigation on the possible transchelation of Gd3 + to the glycosaminoglycan heparin","volume":"8","year":"2013","journal-title":"Contrast Media Mol Imaging"},{"key":"bib50-20231021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00004424-200102000-00008","article-title":"Stability of MRI paramagnetic contrast media: a proton relaxometric protocol for transmetallation assessment","volume":"36","year":"2001","journal-title":"Invest Radiol"},{"key":"bib51-20231021","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3109\/10408444.2014.955568","article-title":"The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: a critical update","volume":"44","year":"2014","journal-title":"Crit Rev Toxicol"},{"key":"bib52-20231021","doi-asserted-by":"crossref","first-page":"16426","DOI":"10.1002\/chem.201202930","article-title":"Dissociation kinetics of open-chain and macrocyclic gadolinium(III)-aminopolycarboxylate complexes related to magnetic resonance imaging: catalytic effect of endogenous ligands","volume":"18","year":"2012","journal-title":"Chemistry"},{"key":"bib53-20231021","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10534-011-9422-9","article-title":"The role of phosphate on Omniscan(\u00ae) dechelation: an in vitro relaxivity study at pH 7","volume":"24","year":"2011","journal-title":"Biometals"},{"key":"bib54-20231021","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.bbamem.2017.02.019","article-title":"Gadolinium released by the linear gadolinium-based contrast-agent Gd-DTPA decreases the activity of human epithelial Na+ channels (ENaCs)","volume":"1859","year":"2017","journal-title":"Biochim Biophys Acta"}],"container-title":["Investigative Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004424-201806000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T05:21:25Z","timestamp":1697865685000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004424-201806000-00002"}},"subtitle":["A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats"],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rli.0000000000000447","relation":{},"ISSN":["1536-0210","0020-9996"],"issn-type":[{"value":"1536-0210","type":"electronic"},{"value":"0020-9996","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}